Librarian View
LEADER
01958cam a22004214a 4500
001
8912812
005
20110329151024.0
008
090213s2009 dcua b 001 0 eng
010
|a
2009006713
024
8
|a
3040294
035
|a
(OCoLC)ocn691250936
035
|a
(NhCcYBP) 2009006713
035
|a
8912812
040
|a
DNLM/DLC
|c
DLC
|d
NLM
|d
BTCTA
|d
C#P
|d
YDXCP
|d
CDX
|d
BWX
|d
NhCcYBP
020
|a
9780844742809
020
|a
0844742805
042
|a
pcc
043
|a
n-us---
050
0
0
|a
HD9675.V333
|b
U6 2009
060
1
0
|a
QW 805
|b
B524u 2009
079
|a
ocn310075923
090
|a
HD9675.V333
|b
U6X 2009 (LC)
100
1
|a
Berndt, Ernst R.
245
1
0
|a
U.S. markets for vaccines :
|b
characteristics, case studies, and controversies /
|c
Ernst R. Berndt, Rena N. Denoncourt, and Anjli C. Warner.
260
|a
Washington, D.C. :
|b
AEI Press ;
|a
Blue Ridge Summit, PA :
|b
Distributed to the trade by National Book Network,
|c
2009.
300
|a
xi, 236 p. :
|b
ill. ;
|c
23 cm.
504
|a
Includes bibliographical references (p. 205-226) and index.
505
0
|a
Envisaging and developing a vaccine -- Planning for vaccine launch -- Rolling out the new vaccine -- Diphtheria, tetanus, and pertussis and related combination vaccines -- Seasonal influenza vaccines -- Prevnar : the seven-valent pneumococcal conjugate vaccine -- Varicella zoster vaccines -- Challenges in maintaining public trust in vaccine safety -- Beyond the turning point: the expanding focus of vaccine R&D.
650
0
|a
Vaccines industry
|z
United States.
650
0
|a
Market surveys
|z
United States.
650
1
2
|a
Vaccines
|x
economics
|z
United States.
650
2
2
|a
Drug Discovery
|x
economics
|z
United States.
650
2
2
|a
Drug Industry
|x
economics
|z
United States.
700
1
|a
Denoncourt, Rena N.
700
1
|a
Warner, Anjli C.
901
|a
HD9675.V333
902
|a
Marx Library
|b
MARX Library >> HD9675.V333 U6X 2009 (LC)|DELIM|9310491
907
|a
2009-07-28T11:50:24.000Z